Health Canada officials discuss approval of Moderna COVID-19 vaccine – December 23, 2020
Federal health officials hold a news conference on Parliament Hill to provide an update on Health Canada’s approval of Moderna’s COVID-19 vaccine. Speaking with reporters are Dr. Supriya Sharma, a senior medical advisor with Health Canada, and Dr. Marc Berthiaume, the director of the Bureau of Medical Science at Health Canada. This is the second COVID-19 vaccine to be approved for use in Canada. The Pfizer-BioNTech vaccine was approved on December 9 and the first vaccinations in the country began on December 14. Up to 168,000 doses of the Moderna vaccine are expected to arrive in Canada by the end of 2020. Unlike the Pfizer vaccine, Moderna’s does not need to be stored in specialized freezers at extremely cold temperatures. Health Canada’s approval means that COVID-19 vaccinations can begin in Canada’s northern regions, as well as remote and Indigenous communities.